Physician profile
Robert G Hale
NPI 1366404410
$230,317.69
in general payments reported to CMS, 2019-2025
6 companies · $166K in 2025
The $166K reported for 2025 was more than what 99% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $722 · 2020: $17.49 · 2023: $4,477 · 2024: $59K · 2025: $166K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $227K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Travel and Lodging: $817 · Food and Beverage: $537 · Education: $59.00 · Gift: $30.30 · Entertainment: $14.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $226,620.73 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Travel and Lodging | $816.54 |
| Food and Beverage | $537.36 |
| Education | $59.00 |
| Gift | $30.30 |
| Entertainment | $14.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $226,620.73 | 2023-2025 | Ips |
| Synthes Gmbh | $2,462.39 | 2023 | |
| Nobel Biocare USA | $670.92 | 2019-2023 | Nobelactive |
| Keystone Dental INC. | $274.81 | 2020-2025 | |
| Straumann USA LLC | $179.95 | 2019-2023 | |
| Salvin Dental Specialties, INC. | $108.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.